Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CT048
i
Other names:
KJC1807, CT048, KJ-C1807, CT 048, KJ C1807, CT-048
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
CARsgen
Drug class:
CLDN18.2-targeted CAR-T immunotherapy
Related drugs:
‹
CT041 (4)
IBI-345 (3)
AZD6422 (0)
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
HEC-016 (0)
IM92 (0)
IMC002 (0)
IMC008 (0)
KD-182 (0)
KD-496 (0)
LB1908 (0)
LY011 (0)
XKDCT086 (0)
anti-Claudin 18.2 CAR-T cell therapy (0)
CT041 (4)
IBI-345 (3)
AZD6422 (0)
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T cells (0)
HEC-016 (0)
IM92 (0)
IMC002 (0)
IMC008 (0)
KD-182 (0)
KD-496 (0)
LB1908 (0)
LY011 (0)
XKDCT086 (0)
anti-Claudin 18.2 CAR-T cell therapy (0)
›
Associations
News
Trials
Filter by
Latest
over1year
Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors (clinicaltrials.gov)
P1, N=63, Recruiting, Peking University | Not yet recruiting --> Recruiting
over 1 year ago
Enrollment open • CAR T-Cell Therapy • Metastases
|
CLDN18 (Claudin 18)
|
CLDN18.2 expression
|
CT048
over2years
Claudin18.2-redirected Chimeric Antigen Receptor T Cells With Co-expression of Cytokines in Solid Tumors (clinicaltrials.gov)
P1, N=63, Not yet recruiting, Peking University
over 2 years ago
New P1 trial • CAR T-Cell Therapy
|
CLDN18 (Claudin 18)
|
CLDN18.2 expression
|
CT048
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login